Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$1.73 - $3.09 $42,066 - $75,136
-24,316 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$2.94 - $4.77 $5,033 - $8,166
-1,712 Reduced 6.58%
24,316 $72,000
Q4 2021

Feb 11, 2022

SELL
$4.07 - $5.3 $134 - $174
-33 Reduced 0.13%
26,028 $117,000
Q3 2021

Nov 12, 2021

BUY
$4.7 - $7.24 $1,912 - $2,946
407 Added 1.59%
26,061 $127,000
Q2 2021

Aug 13, 2021

BUY
$6.81 - $10.93 $1,600 - $2,568
235 Added 0.92%
25,654 $175,000
Q1 2021

May 07, 2021

BUY
$6.14 - $8.31 $411 - $556
67 Added 0.26%
25,419 $179,000
Q4 2020

Feb 12, 2021

SELL
$4.58 - $7.14 $3,334 - $5,197
-728 Reduced 2.79%
25,352 $159,000
Q3 2020

Nov 04, 2020

BUY
$4.19 - $6.69 $4,776 - $7,626
1,140 Added 4.57%
26,080 $141,000
Q2 2020

Aug 12, 2020

BUY
$2.97 - $5.22 $16,284 - $28,621
5,483 Added 28.18%
24,940 $130,000
Q1 2020

May 04, 2020

SELL
$2.67 - $4.97 $3,003 - $5,591
-1,125 Reduced 5.47%
19,457 $61,000
Q4 2019

Feb 05, 2020

BUY
$2.93 - $4.5 $1,084 - $1,665
370 Added 1.83%
20,582 $83,000
Q3 2019

Nov 08, 2019

SELL
$3.08 - $5.76 $434 - $812
-141 Reduced 0.69%
20,212 $87,000
Q2 2019

Aug 13, 2019

SELL
$3.47 - $6.32 $582 - $1,061
-168 Reduced 0.82%
20,353 $81,000
Q1 2019

May 06, 2019

SELL
$5.36 - $7.24 $1,141 - $1,542
-213 Reduced 1.03%
20,521 $110,000
Q4 2018

Feb 13, 2019

SELL
$4.8 - $11.6 $768 - $1,856
-160 Reduced 0.77%
20,734 $106,000
Q3 2018

Nov 09, 2018

BUY
$9.05 - $10.95 $3,411 - $4,128
377 Added 1.84%
20,894 $203,000
Q2 2018

Aug 08, 2018

BUY
$10.2 - $13.9 $35,383 - $48,219
3,469 Added 20.35%
20,517 $209,000
Q1 2018

May 07, 2018

BUY
$12.65 - $18.85 $12,776 - $19,038
1,010 Added 6.3%
17,048 $222,000
Q4 2017

Feb 09, 2018

BUY
$17.45 - $25.6 $4,083 - $5,990
234 Added 1.48%
16,038 $287,000
Q3 2017

Nov 09, 2017

BUY
$18.9 - $28.2 $298,695 - $445,672
15,804
15,804 $397,000

Others Institutions Holding PRTK

About Paratek Pharmaceuticals, Inc.


  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.